Jerome M. Lasker

5.8k total citations · 1 hit paper
62 papers, 4.9k citations indexed

About

Jerome M. Lasker is a scholar working on Pharmacology, Biochemistry and Molecular Biology. According to data from OpenAlex, Jerome M. Lasker has authored 62 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pharmacology, 21 papers in Biochemistry and 16 papers in Molecular Biology. Recurrent topics in Jerome M. Lasker's work include Pharmacogenetics and Drug Metabolism (40 papers), Eicosanoids and Hypertension Pharmacology (19 papers) and Alcohol Consumption and Health Effects (16 papers). Jerome M. Lasker is often cited by papers focused on Pharmacogenetics and Drug Metabolism (40 papers), Eicosanoids and Hypertension Pharmacology (19 papers) and Alcohol Consumption and Health Effects (16 papers). Jerome M. Lasker collaborates with scholars based in United States, United Kingdom and Australia. Jerome M. Lasker's co-authors include Judy L. Raucy, Charles S. Lieber, Martin Black, Alan S. Rosman, Imre Wolf, James C. Kraner, Mikihiro Tsutsumi, Masanori Shimizu, Dennis E. Feierman and Burhan I. Ghanayem and has published in prestigious journals such as Science, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Jerome M. Lasker

61 papers receiving 4.6k citations

Hit Papers

Acetaminophen activation by human liver cytochromes P450I... 1989 2026 2001 2013 1989 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2
    1989 418 citations Judy L. Raucy, Jerome M. Lasker et al. Archives of Biochemistry and Biophysics profile →

Peers

Jerome M. Lasker
Judy L. Raucy United States
F. Berthou France
Dennis R. Koop United States
Richard O. Recknagel United States
Jerry R. Mitchell United States
Yoshihiko Funae Japan
Erik Eliasson Sweden
H. Remmer Germany
Henry W. Strobel United States
Masahiro Tohkin Japan
Judy L. Raucy United States
Jerome M. Lasker
Citations per year, relative to Jerome M. Lasker Jerome M. Lasker (= 1×) peers Judy L. Raucy

Countries citing papers authored by Jerome M. Lasker

Since Specialization
Citations

This map shows the geographic impact of Jerome M. Lasker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome M. Lasker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome M. Lasker more than expected).

Fields of papers citing papers by Jerome M. Lasker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome M. Lasker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome M. Lasker. The network helps show where Jerome M. Lasker may publish in the future.

Co-authorship network of co-authors of Jerome M. Lasker

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome M. Lasker. A scholar is included among the top collaborators of Jerome M. Lasker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome M. Lasker. Jerome M. Lasker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Mei‐Hui, Üzen Savas, Jerome M. Lasker, & Eric F. Johnson. (2011). Genistein, Resveratrol, and 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside Induce Cytochrome P450 4F2 Expression through an AMP-Activated Protein Kinase-Dependent Pathway. Journal of Pharmacology and Experimental Therapeutics. 337(1). 125–136. 39 indexed citations
2.
Raucy, Judy L. & Jerome M. Lasker. (2010). Current In Vitro High Throughput Screening Approaches to Assess Nuclear Receptor Activation. Current Drug Metabolism. 11(9). 806–814. 24 indexed citations
3.
Savas, Üzen, Mei‐Hui Hsu, Pryce Gaynor, et al.. (2009). Opposing Roles of Peroxisome Proliferator-activated Receptor α and Growth Hormone in the Regulation of CYP4A11 Expression in a Transgenic Mouse Model. Journal of Biological Chemistry. 284(24). 16541–16552. 23 indexed citations
4.
Magnusson, Ronald P., et al.. (2008). Expression of CYP4F2 in human liver and kidney: Assessment using targeted peptide antibodies. Archives of Biochemistry and Biophysics. 478(1). 59–68. 31 indexed citations
5.
Lasker, Jerome M., et al.. (2008). Expression of CYP4F2 in human liver and kidney: assessment using specific peptide antibodies. The FASEB Journal. 22(S1).
6.
Raucy, Judy L., et al.. (2004). CONVERSION OF THE HIV PROTEASE INHIBITOR NELFINAVIR TO A BIOACTIVE METABOLITE BY HUMAN LIVER CYP2C19. Drug Metabolism and Disposition. 32(12). 1462–1467. 46 indexed citations
7.
Raucy, Judy L., et al.. (2002). Expression and Induction of CYP2C P450 Enzymes in Primary Cultures of Human Hepatocytes. Journal of Pharmacology and Experimental Therapeutics. 302(2). 475–482. 104 indexed citations
8.
Lasker, Jerome M., et al.. (2000). Formation of 20-Hydroxyeicosatetraenoic Acid, a Vasoactive and Natriuretic Eicosanoid, in Human Kidney. Journal of Biological Chemistry. 275(6). 4118–4126. 264 indexed citations
9.
Lasker, Jerome M., et al.. (1998). Characterization of CYP2C19 and CYP2C9 from Human Liver: Respective Roles in Microsomal Tolbutamide,S-Mephenytoin, and Omeprazole Hydroxylations. Archives of Biochemistry and Biophysics. 353(1). 16–28. 124 indexed citations
10.
Cretton-Scott, Erika, et al.. (1998). Role of Human Liver P450s and Cytochrome b5 in the Reductive Metabolism of 3′-Azido-3′-deoxythymidine (AZT) to 3′-Amino-3′-deoxythymidine. Biochemical Pharmacology. 55(6). 757–766. 25 indexed citations
11.
Wolf, Imre, et al.. (1998). Metabolism of Arachidonic Acid to 20-Hydroxy-5,8,11,14-eicosatetraenoic Acid by P450 Enzymes in Human Liver: Involvement of CYP4F2 and CYP4A11. Journal of Pharmacology and Experimental Therapeutics. 285(3). 1327–1336. 181 indexed citations
12.
Rao, D. N., et al.. (1996). 1-Hydroxyethyl radical formation during NADPH- and NADH-dependent oxidation of ethanol by human liver microsomes.. Molecular Pharmacology. 49(5). 814–821. 29 indexed citations
13.
Goldstein, Jorge, M B Faletto, Terry Sullivan, et al.. (1994). Evidence That CYP2C19 is the Major (S)-Mephenytoin 4'-Hydroxylase in Humans. Biochemistry. 33(7). 1743–1752. 316 indexed citations
14.
Tsutsumi, Mikihiro, Jerome M. Lasker, Tsutomu Takahashi, & C S Lieber. (1993). In Vivo Induction of Hepatic P4502E1 by Ethanol: Role of Increased Enzyme Synthesis. Archives of Biochemistry and Biophysics. 304(1). 209–218. 87 indexed citations
15.
Leo, Maria A., et al.. (1990). Interaction of Ethanol with Enflurane Metabolism and Toxicity: Role of P450IIE1. Alcoholism Clinical and Experimental Research. 14(2). 174–179. 35 indexed citations
16.
Leo, Maria A., Jerome M. Lasker, Judy L. Raucy, et al.. (1989). Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Archives of Biochemistry and Biophysics. 269(1). 305–312. 147 indexed citations
17.
Tsutsumi, Mikihiro, Jerome M. Lasker, Masanori Shimizu, Alan S. Rosman, & Charles S. Lieber. (1989). The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology. 10(4). 437–446. 274 indexed citations
18.
Lieber, C S, et al.. (1988). Role of acetone, dietary fat and total energy intake in induction of hepatic microsomal ethanol oxidizing system.. Journal of Pharmacology and Experimental Therapeutics. 247(2). 791–795. 65 indexed citations
19.
Lasker, Jerome M., et al.. (1987). Purification and characterization of human liver cytochrome P-450-ALC. Biochemical and Biophysical Research Communications. 148(1). 232–238. 108 indexed citations
20.
Lasker, Jerome M., et al.. (1984). In vitro and in vivo activation of oxidative drug metabolism by flavonoids.. Journal of Pharmacology and Experimental Therapeutics. 229(1). 162–170. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judy L. Raucy Breakdown of academic impact, for papers by F. Berthou Breakdown of academic impact, for papers by Dennis R. Koop Breakdown of academic impact, for papers by Richard O. Recknagel Breakdown of academic impact, for papers by Jerry R. Mitchell Breakdown of academic impact, for papers by Yoshihiko Funae Breakdown of academic impact, for papers by Erik Eliasson Breakdown of academic impact, for papers by H. Remmer Breakdown of academic impact, for papers by Henry W. Strobel Breakdown of academic impact, for papers by Masahiro Tohkin
Rankless by CCL
2026